Skip to main content
Clinical Trials/DRKS00008196
DRKS00008196
Completed
Not Applicable

Prospective registry study investigating medical care in hematooncologic patients with venousthromboembolism in Berlin - GECAT – German Evaluation of Cancer associated Thrombosis

Vivantes Klinikum im FriedrichshainKlinik für Innere Medizin/Angiologie , Funktionsbereich Hämostaseologie0 sites382 target enrollmentMay 18, 2015

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Not specified
Sponsor
Vivantes Klinikum im FriedrichshainKlinik für Innere Medizin/Angiologie , Funktionsbereich Hämostaseologie
Enrollment
382
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
May 18, 2015
End Date
May 1, 2017
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Sponsor
Vivantes Klinikum im FriedrichshainKlinik für Innere Medizin/Angiologie , Funktionsbereich Hämostaseologie

Eligibility Criteria

Inclusion Criteria

  • Patients with malignant disease of any kind and newly diagnosed venous thromboembolism who received inpatient or outpatient treatment in the hospitals of Vivantes/Charite. The malignant disease should have been diagnosed or have required treatment during the past two years.Patients with venous thromboembolism in whom malignant disease is diagnosed for the first time, in the course of diagnostic procedures due to venous thrombembolism

Exclusion Criteria

  • Patients suffering venous thromboembolism but not malignant disease will be registered only once by with reduced baseline documentation. There will be no follow up. They will not take part in follow\-up\-investigation.

Outcomes

Primary Outcomes

Not specified

Similar Trials